Barrigel, by Palette Life Sciences, is an injectable biodegradable rectal spacer that separates the prostate from the rectum to protect it during radiation therapy treatment for prostate cancer. Barrigel is made from Non-Animal Stabilized Hyaluronic Acid (NASHA®), which has been proven safe and effective, and has been used for more than 20 years in over 50 million medical procedures worldwide. A groundbreaking spacing technology, it is the first and only hyaluronic acid, visually-guided, sculptable spacer, for patients undergoing radiotherapy treatment for prostate cancer. Learn more at Barrigel.com.
Boston Scientific partners with physicians to continually advance the quality of patient care with innovative solutions so you can choose the right technology and the right technique for every patient – without compromise. Visit our booth and speak with a representative to learn more.
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.
An industry pioneer & leader, Theragenics Celebrates 40 Years of Forward Thinking in the global supply of LDR brachytherapy seeds for the treatment of prostate cancer, intra-ocular malignancies, and other tumor types with radiosensitivity. To learn more about our industry benchmark recognized sources, TheraSeed® Pd-103 & AgX100® I-125, please visit www.theragenics.com.
Imagine a world free from the fear of cancer. We do, every day. That’s why at Varian, a Siemens Healthineers Company, we’re obsessed with creating simpler, more efficient, and more effective technologies to power new victories in cancer care. From afterloaders to applicators, and a range of software tools for planning LDR and HDR brachytherapy treatments, Varian technology helps you give your patients the treatments they need, exactly where they need it. To learn more about our solutions, go to http://www.varian.com.
Best Medical International, Inc.
For more than 40 years, Best Medical has served the medical community with the highest quality products and unparalleled customer service. Our brachytherapy (Iodine/Pd/Iridium/Gold) seeds, gold fiducial markers, supplies, accessories (needles, templates, applicators, catheters) and other products exemplify our commitment to uncompromised quality and safety. Best Medical International now encompasses a family of trusted companies and organizations with a proven track record of innovation, quality and service in external beam radiation therapy, brachytherapy and vascular brachytherapy solutions. Our aim is to be the one partner that clinicians turn to for all their radiotherapy and oncology product and service requirements.
MIM Software Inc.
MIM Software Inc. offers:
Adaptiiv allows clinicians to create personalized brachytherapy applicators with proprietary software and 3D printing. The company's software democratizes the design of patient-specific applicators which are digitally manufactured using the latest 3D printing technology and innovative materials. Adaptiiv's 3D printed applicators provide a level of quality, precision, and accuracy which are clinically, operationally, and financially superior to the status quo. This ultimately ensures patients can receive personalized care on time and as planned.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com
BK Medical systems
Now part of GE HealthCare, BK Medical is pushing the boundaries of interoperative ultrasound for the prostate and surrounding structures. With 40 years of experience BK Medical is your trusted partner during radiation oncology procedures. Our systems provide high resolution imaging for needle guidance and source placement, in combination with a variety of specialized transducers. Available across our portfolio of systems is the option to include the unique experience of the fully-integrated digital planning software.
Ultrasound Machines for Brachytherapy | BK Medical
CivaTech Oncology is dedicated to localized radiation, precision therapy, without the beam. The implantable CivaSheet ® features a polymer encapsulated Pd-103 source, the only LDR brachytherapy device customizable to a specific patient and unidirectional to shield healthy tissue- the Gold side is Cold! CivaString ® is also a Pd-103 source with a unique linear radioactive distribution providing refinement on traditional prostate seeds- all polymer, no titanium, less needles, less swelling, less symptoms. And CivaDerm ® is FDA cleared surface radiation therapy, a one time, 5-day bandage that delivers a curative dose to treat non melanoma skin cancers.
CIVCO Radiotherapy & Qfix
CIVCO Radiotherapy & Qfix is a global leader in developing high-quality, innovative, patient-centric radiotherapy solutions. The company has over 80 years of combined experience bringing advanced hardware and consumables for patient immobilization and positioning, fiducial markers, couchtops, and patient care products to the market. Visit www.CivcoRT.com and www.Qfix.com for more information.
As the manufacturer of Advantage™ I-125 and Pd-103 seeds for over 20 years, IsoAid specializes in providing Brachytherapy seeds for the treatment of prostate, ocular and breast cancer, as well as for diagnostic localization purposes. We are a full-service company you can always rely on, making seeds at the activity you request, custom-loading and delivering them faster than anyone in the industry. Through our exclusive partnership with Eye Physics we give you access to cutting edge eye plaques and planning services, which deliver many clinical advantages to you and your patients. High-activity seeds are custom-loaded using COMS or Eye Physics plaques. Our innovate Secure Strand™ cuts down significantly on seed migration for prostate patients and is now being used for RSL with great success. Our team of experts is dedicated to helping with every aspect of your program and is happy to serve as a complete resource for you. IsoAid is invested in the future of Brachytherapy and we look forward to introducing you to some exciting new advances very soon.
Orfit brings high precision and comfort to the positioning and immobilization of cancer patients in Radiation Oncology. The Zephyr HDR system utilizes patented hover technology to allow patient transfer from procedure to imaging to treatment while maintaining patient positioning and minimizing the risk of needle/applicator displacement. Integrating Zephyr HDR for your brachytherapy procedures allows the incorporation of valuable 3D dosimetric data from CT/MR imaging, providing more accuracy in today’s brachytherapy procedures. Visit www.orfit.com for more information.
Perspective Therapeutics is a precision oncology company focused on targeted alpha particle therapies (TAT) and innovative brachytherapy solutions intended to treat cancer from the inside out. The company's development pipeline is focused on Lead-212 alpha particle-based radiopharmaceuticals for the diagnosis and treatment of NETs, melanoma and other solid tumors. The commercial pipeline is focused on Cesium-131 seed brachytherapy for the treatment of prostate, brain and head and neck cancers.
Alpha Tau Medical
Alpha Tau Medical develops and commercialize the Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), an innovative technology that enables the highly potent and uniquely conformal alpha-irradiation of solid tumors. The treatment is delivered by intratumoral insertion of radionuclide Radium-224, which leads to the release and diffusion of daughter radioisotopes that emit alpha particles. These alpha particles have the capacity to destroy solid tumors. Since the alpha-emitting atoms diffuse only a short distance in tissue, Alpha DaRT mainly damages the tumor, while sparing the healthy tissue around it.
C4 Imaging develops innovative medical devices that enable clinicians to personalize patient care through accurate image-guided procedures. The company's core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has been encapsulated within a variety of implantable, biocompatible shells.
Empyrean Medical Systems Inc.
Empyrean Medical Systems Inc. is dedicated to making a difference for clinicians, patients and loved ones touched by cancer.
Morpheus™= The Easy Radiation Solution.
Robotically assisted, Morpheus™ is a rapid and accurate platform used to deliver radiation during Brachytherapy and/or surgical procedures (IORT). Morpheus™ easily moves between suites, has beam-sculpting capability- avoiding organs at risk and provides true dosimetry. Morpheus™ is an easy, yet sophisticated treatment choice for clinicians and patients in the fight against cancer.
Description: GammaTile is FDA-cleared to treat operable brain tumors including newly diagnosed malignant and recurrent brain tumors. Implanted during brain tumor resection, GammaTile uses collagen tiles that are embedded with radiation sources providing an immediate, dose-intense treatment to eliminate residual tumor cells. This "one and done" procedure allows patients to receive radiation while going about their daily lives, requiring no additional trips to the hospital or clinic for radiation therapy.
Gold Anchor MR+ is a fiducial marker with proven clinical benefits: our industry leading thin needles enable safe implantation in almost any inner organ; the unique folding marker design allows for no lead time between implantation and CT/MRI; the markers can be tracked for intrafraction motion management; and the patented marker material (1.5% pure iron in an alloy with gold) provides enhanced MRI visibility especially on T2-weighted images.
Limbus AI Inc.
Limbus AI stands at the forefront of AI automatic contouring solutions, delivering expert-level accuracy, and can be installed locally on existing workstations. Our flagship offering, the Limbus Contour platform, is a fast, automated, turnkey, and secure solution for cancer radiation therapy. Backed by comprehensive research, our robust and consistent CT and MRI models have been fully validated. With its lightweight design, Limbus Contour seamlessly integrates into any clinical workflow, saving valuable time and facilitating immediate application on your data.
Revenue Cycle Coding Strategies
Revenue Cycle Coding Strategies is the premier provider of healthcare compliance resources and services. We provide custom solutions for consulting, auditing, coding, revenue optimization, education, and resources across most specialties. Healthcare compliance: It's in our DNA.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
* Subject to regulatory clearance in some markets.